CT
Menu
Search
Sections
Home
News
Analysis
Features
Comment
Projects
Data Insights
Sectors
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Themes
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Product & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Magazine
Newsletters
GlobalData
About Us
Advertise With Us
Contact Us
Our Marketing Solution
GlobalData Reports
Visit GlobalData
From Our Partners
Accelerating Clinical Trials
Advancing research with digital-first clinical trials
AI and clinical trials
Future Pharma Services
Specialty drug launch strategy and operations
The next chapter of clinical trial services
Trusted clinical trial packaging services
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
Are decentralised clinical trials actually patient-centric?
World Contraception Day – a day to create awareness of contraception
Promise for Relmada Therapeutics’s antidepressant REL-1017, but more data required
Sectors
Sections
Clinical Trials
Approvals
Operations
Outsourced Services
Supply Chain
Data Management
Medical Devices
Latest
Recce completes dosing of healthy subjects in UTI therapy trial
YS Biopharma enrols first subject in PIKA Rabies Vaccine study
Axial Therapeutics concludes enrolment in TAPESTRY Autism Study
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Latest
Medidata unveils new solution to boost clinical trial diversity
Dassault launches digital twin ‘Emma’
Corporate sustainability needs ESG standards and tools
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Signal: Eli Lilly’s $176.5m Teva patent infringement loss overturned in US
Signal: AbbVie ends multi-million dollar cancer drug deal with I-Mab
Signal: CMR Surgical Raises $165m to continue development of surgical robot
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
How serialization will shape the future of the pharma industry
How CATs can enhance clinical trials
Outsourcing trends in clinical trials: How one company is reimagining the FSP model
Events
Reports
Premium Insights
Newsletters
CT
All articles by Sophia Devi
Sophia Devi
Data Insights
Artificial Intelligence innovation: Leading companies in DNA polymorphism detection for the pharmaceutical industry
Data Insights
Innovation in immuno-oncology: Leading companies in cancer chimeric antigen receptor (CAR) T-cell therapy
Comment
Top tweets: Tea consumption and mortality risk – and more
Comment
Top tweets: Poor diet being the cause of Covid-19 deaths at NHS and more
Comment
Twitter: Dr. Dave Stukus on unproven diagnostic tests top tweet Q1 2022
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Sign up
View more
Most Popular
Novartis eyes accelerated FDA approval for iptacopan across multiple indications
AbbVie’s venetoclax fails Phase III myeloma trial
Phase III results boost datopotomab deruxtecan’s potential in breast cancer
